Similarly, CD8+ T-cell subsets producing IL-17 and IL-17/IFN-γ increased in patients with MG, whereas the increased cell levels were inhibited by the retinoic acid receptor-related-orphan-receptor-C (RORγ) inhibitor. The gene discussed is RORC; the disease is myasthenia gravis.